[Targeted drugs in radiation therapy]

Area of Science:

• Oncology
• Radiation Oncology
• Molecular Biology

Background:

• Targeted therapies are explored in combination with ionizing radiation to enhance tumor cell eradication.
• Targeted drugs often have limited cytotoxic potential, necessitating combination with cytotoxic agents.
• Low cumulative toxicity is an expected benefit of targeted drugs.

Purpose of the Study:

• To evaluate the efficacy of targeted therapies in combination with ionizing radiation.
• To investigate the mechanisms underlying radiation-drug interactions.
• To identify strategies for potentiating radiotherapy response.

Main Methods:

• Assaying new targeted drugs in combination with ionizing radiation.
• Investigating targeted drug mechanisms, including inhibition of protein modifications (e.g., phosphorylation, prenylation).
• Examining various cellular systems (proteasome, neoangiogenesis, TGF-beta, cyclooxygenase, NF-kappaB) for therapeutic control.

Main Results:

• Most targeted drug and radiation combinations showed strictly additive effects on cell growth inhibition and cell death.
• A few targeted drugs demonstrated antitumor potential in specific phenotypes.
• Potentiation of radiotherapy response was not consistently achieved with current targeted agents.

Conclusions:

• Current targeted therapies combined with radiation offer limited synergistic antitumor effects.
• Enhanced radiotherapy potentiation may necessitate targeting DNA repair mechanisms.
• Further research is needed to develop targeted agents that synergize effectively with radiation therapy.